These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14595814)

  • 1. Identification of repertoires of surface antigens on leukemias using an antibody microarray.
    Belov L; Huang P; Barber N; Mulligan SP; Christopherson RI
    Proteomics; 2003 Nov; 3(11):2147-54. PubMed ID: 14595814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
    Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
    J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of AML using a monoclonal antibody microarray.
    Christopherson RI; Stoner K; Barber N; Belov L; Woolfson A; Scott M; Bendall L; Mulligan SP
    Methods Mol Med; 2006; 125():241-51. PubMed ID: 16502589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody to human leukocyte common antigen, SHL-1, and its use for formalin-fixed, paraffin-embedded tissues.
    Park SH; Lee GK; Bae YM; Kim CJ; Song HG; Kim CW; Chi JG; Lee SK
    Pathol Res Pract; 1991 Jan; 187(1):96-102. PubMed ID: 2027826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.
    Anderson KC; Bates MP; Slaughenhoupt BL; Pinkus GS; Schlossman SF; Nadler LM
    Blood; 1984 Jun; 63(6):1424-33. PubMed ID: 6609729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
    Belov L; Mulligan SP; Barber N; Woolfson A; Scott M; Stoner K; Chrisp JS; Sewell WA; Bradstock KF; Bendall L; Pascovici DS; Thomas M; Erber W; Huang P; Sartor M; Young GA; Wiley JS; Juneja S; Wierda WG; Green AR; Keating MJ; Christopherson RI
    Br J Haematol; 2006 Oct; 135(2):184-97. PubMed ID: 16939496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation antigens of malignant leukocytes (2)].
    Bernard A; Boumsell L
    Presse Med; 1984 Nov; 13(39):2371-4, 2379-80. PubMed ID: 6239204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The applicability of a cluster of differentiation monoclonal antibody microarray to the diagnosis of human disease.
    Ellmark P; Woolfson A; Belov L; Christopherson RI
    Methods Mol Biol; 2008; 439():199-209. PubMed ID: 18370105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
    Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T
    Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance.
    Menon M; Drexler HG; Minowada J
    Leuk Res; 1986; 10(1):25-8. PubMed ID: 3080642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell surface antigens in leukemias and lymphomas.
    Freedman AS
    Cancer Invest; 1996; 14(3):252-76. PubMed ID: 8630688
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues.
    Knowles DM; Tolidjian B; Marboe CC; Mittler RS; Talle MA; Goldstein G
    Blood; 1984 Apr; 63(4):886-96. PubMed ID: 6423012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical applications of leukocyte surface molecules--the CD molecules.
    Zola H
    Mol Med; 2006; 12(11-12):312-6. PubMed ID: 17380197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.